Medscape Conference Coverage, based on selected sessions at the:

6th European Breast Cancer Conference (EBCC)

April 15 - 19, 2008; Berlin, Germany

This activity is not sanctioned by, nor a part of, the European Cancer Organisation.

Conference News

  • Lapatinib May Target Breast Cancer Stem Cells

    In a small trial of locally advanced breast cancer, lapatinib monotherapy for 6 weeks resulted in significant tumor regression, suggesting that it targets cancer stem cells.Medscape Medical News, April 18, 2008
  • Acupuncture for Tamoxifen-Induced Hot Flushes

    Acupuncture reduced by half the hot flushes experienced by breast cancer patients taking tamoxifen after surgery to prevent a recurrence.Medscape Medical News, April 18, 2008
  • Prophylactic Mastectomy for BRCA Gene Mutations

    Women who carry BRCA gene mutations are highly predisposed to breast cancer, but prophylactic mastectomy can reduce the risk to less than 1%, which frees these women from continued intensive surveillance, say researchers.Medscape Medical News, April 16, 2008
  • Treatment for Pregnant Breast Cancer Patients

    Data from a German registry show that fetal outcomes were similar in women who did and did not receive chemotherapy, suggesting that pregnant patients need not miss out on treatment.Medscape Medical News, April 16, 2008
  • Preoperative MRI for Breast Cancer

    Preoperative MRI should be standard in tumor staging before breast conservation surgery, say researchers reporting changes in management after such imaging.Medscape Medical News, April 16, 2008

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the European Cancer Organisation. These materials and the related activity are not sanctioned by the European Cancer Organisation or the commercial supporter of the conference and do not constitute an official part of that conference.